share_log

VistaGen Therapeutics | 8-K: Vistagen Reports Fiscal 2024 Third Quarter Financial Results and Provides Corporate Update

SEC announcement ·  Feb 13 16:35
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more